This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jugovic, P.
Right arrow Articles by Johnson, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jugovic, P.
Right arrow Articles by Johnson, D. C.

 Previous Article  |  Next Article 

J Virol, June 1998, p. 5076-5084, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Inhibition of Major Histocompatibility Complex Class I Antigen Presentation in Pig and Primate Cells by Herpes Simplex Virus Type 1 and 2 ICP47

Pieter Jugovic,1,dagger Ann M. Hill,1 Roman Tomazin,1 Hidde Ploegh,2,Dagger and David C. Johnson1,*

Department of Molecular Microbiology & Immunology, Oregon Health Sciences University, Portland, Oregon,1 and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts2

Received 16 December 1997/Accepted 19 February 1998

Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) express an immediate-early protein, ICP47, that effectively inhibits the human transporter associated with antigen presentation (TAP), blocking major histocompatibility complex (MHC) class I antigen presentation to CD8+ T cells. Previous work indicated that the mouse TAP is relatively resistant to inhibition by the HSV-1 and HSV-2 ICP47 proteins (ICP47-1 and ICP47-2) and that mouse cells infected with HSV-1 are lysed by anti-HSV CD8+ cytotoxic T lymphocytes (CTL). Therefore, mice are apparently not suitable animals in which to study the in vivo effects of ICP47. In order to find an animal model, we introduced ICP47-1 and ICP47-2 into cells from various animal species---mice, rats, guinea pigs, rabbits, dogs, pigs, cows, monkeys, and humans---and measured TAP activity in the cells. Both proteins were unable to inhibit TAP in mouse, rat, guinea pig, and rabbit cells. In contrast, ICP47-1 and ICP47-2 inhibited TAP in pig, dog, cow, and monkey cells, and the TAP in pig and dog fibroblasts was often more sensitive to both proteins than TAP in human fibroblasts. These results were extended by measuring CD8+-T-cell recognition (CTL lysis) of cells from various species. Cells were infected with recombinant HSV-1 constructed to express murine MHC class I proteins so that the cells would be recognized and lysed by well-characterized murine anti-HSV CTL unless antigen presentation was blocked by ICP47. Anti-HSV CD8+ CTL effectively lysed pig and primate cells infected with a recombinant HSV-1 ICP47- mutant but were unable to lyse pig or primate cells infected with a recombinant HSV-1 that expressed ICP47. Therefore, pigs, dogs, and monkeys may be useful animal models in which to test the effects of ICP47 on HSV pathogenesis or the use of ICP47 as a selective immunosuppressive agent.

* Corresponding author. Mailing address: L-220, Dept. of Molecular Microbiology & Immunology, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Rd., Portland, OR 97201. Phone: (503) 494-0834. Fax: (503) 494-6862. E-mail: johnsoda{at}ohsu.edu.

dagger Present address: University of Toronto Medical School, Toronto, Ontario, Canada.

Dagger Present address: Department of Pathology, Harvard Medical School, Boston, Mass.

J Virol, June 1998, p. 5076-5084, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Zahariadis, G., Wagner, M. J., Doepker, R. C., Maciejko, J. M., Crider, C. M., Jerome, K. R., Smiley, J. R. (2008). Cell-Type-Specific Tyrosine Phosphorylation of the Herpes Simplex Virus Tegument Protein VP11/12 Encoded by Gene UL46. J. Virol. 82: 6098-6108 [Abstract] [Full Text]  
  • van Hall, T., Laban, S., Koppers-Lalic, D., Koch, J., Precup, C., Asmawidjaja, P., Offringa, R., Wiertz, E. J. H. J. (2007). The Varicellovirus-Encoded TAP Inhibitor UL49.5 Regulates the Presentation of CTL Epitopes by Qa-1b1. J. Immunol. 178: 657-662 [Abstract] [Full Text]  
  • Flano, E., Kayhan, B., Woodland, D. L., Blackman, M. A. (2005). Infection of Dendritic Cells by a {gamma}2-Herpesvirus Induces Functional Modulation. J. Immunol. 175: 3225-3234 [Abstract] [Full Text]  
  • Liu, R., Varghese, S., Rabkin, S. D. (2005). Oncolytic Herpes Simplex Virus Vector Therapy of Breast Cancer in C3(1)/SV40 T-antigen Transgenic Mice. Cancer Res. 65: 1532-1540 [Abstract] [Full Text]  
  • Berkhoff, E. G. M., Boon, A. C. M., Nieuwkoop, N. J., Fouchier, R. A. M., Sintnicolaas, K., Osterhaus, A. D. M. E., Rimmelzwaan, G. F. (2004). A Mutation in the HLA-B*2705-Restricted NP383-391 Epitope Affects the Human Influenza A Virus-Specific Cytotoxic T-Lymphocyte Response In Vitro. J. Virol. 78: 5216-5222 [Abstract] [Full Text]  
  • Aurelian, L. (2004). Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?. CVI 11: 437-445 [Abstract] [Full Text]  
  • Lacayo, J., Sato, H., Kamiya, H., McVoy, M. A. (2003). Down-regulation of surface major histocompatibility complex class I by guinea pig cytomegalovirus. J. Gen. Virol. 84: 75-81 [Abstract] [Full Text]  
  • Mikloska, Z., Bosnjak, L., Cunningham, A. L. (2001). Immature Monocyte-Derived Dendritic Cells Are Productively Infected with Herpes Simplex Virus Type 1. J. Virol. 75: 5958-5964 [Abstract] [Full Text]  
  • Miller, C. G., Fraser, N. W. (2000). Role of the Immune Response during Neuro-attenuated Herpes Simplex Virus-mediated Tumor Destruction in a Murine Intracranial Melanoma Model. Cancer Res. 60: 5714-5722 [Abstract] [Full Text]  
  • Ambagala, A. P. N., Hinkley, S., Srikumaran, S. (2000). An Early Pseudorabies Virus Protein Down-Regulates Porcine MHC Class I Expression by Inhibition of Transporter Associated with Antigen Processing (TAP). J. Immunol. 164: 93-99 [Abstract] [Full Text]  
  • Hansen, J. D., Strassburger, P., Thorgaard, G. H., Young, W. P., Du Pasquier, L. (1999). Expression, Linkage, and Polymorphism of MHC-Related Genes in Rainbow Trout, Oncorhynchus mykiss. J. Immunol. 163: 774-786 [Abstract] [Full Text]  
  • Todo, T., Martuza, R. L., Rabkin, S. D., Johnson, P. A. (2001). Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc. Natl. Acad. Sci. USA 98: 6396-6401 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»